Patient experience of head and neck lymphedema therapy: a qualitative study
Lymphedema is a common late effect from head and neck cancer and/or its treatment. Guidelines recommend that patients with lymphedema should be referred for therapy in a timely manner to maximize control of lymphedema-related symptoms. However, there is paucity of information regarding treatment outcomes in the head and neck cancer population. To address this gap, we conducted a qualitative study to gain understanding of head and neck cancer patients’ experience pertaining to lymphedema therapy, barriers to treatment, perceptions concerning physical and psychological benefits, opinions about therapists, and suggestions to enhance outcomes.
Twenty head and neck cancer patients who underwent lymphedema therapy completed semi-structured face-to-face interviews. Interviews were audio-recorded, and verbatim transcriptions were completed. Thematic analysis was employed to analyze the interview data.
A majority of the participants (n = 15, 75%) completed a full course of lymphedema treatment. Most participants expressed physical (n = 18, 90%) and psychological (n = 14, 70%) benefits about the lymphedema therapy, e.g., decreased swelling, increased swallowing function, and multi-faceted healing. More than one third of the participants described barriers hampering their lymphedema therapy, e.g., insurance coverage, return to work, and availability of lymphedema therapy. Many participants proposed suggestions for improvement of lymphedema therapy, e.g., personalized education, longer treatment time, and caregiver education.
The study has underscored the potential benefit of lymphedema therapy in the head and neck cancer population. Substantial barriers to therapy were reported and need to be addressed. Opportunities to improve lymphedema therapy outcomes were suggested. Personalized strategies should be considered for ensuring optimal patient outcomes.
KeywordsHead and neck cancer Lymphedema Lymphedema therapy Experience Qualitative
This research was supported by the Vanderbilt Office of Clinical and Translational Scientist Development and American Cancer Society.
Compliance with ethical standards
The study was approved by the Institutional Review Board at Vanderbilt University and the Scientific Review Committee at the Vanderbilt-Ingram Cancer Center (VICC).
Conflict of interest
The authors declare that they have no conflict of interest.
Written informed consent forms were obtained from all participants prior to initiating any study-related research activities
- 5.Deng J, Ridner SH, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Murphy BA (2012b) Factors associated with external and internal lymphedema in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 84(3):e319–e328. https://doi.org/10.1016/j.ijrobp.2012.04.013 CrossRefGoogle Scholar
- 8.Zuther JE (2009) Lymphedema management: the comprehensive guide for practitioners, 2nd edn. Thieme, New YorkGoogle Scholar
- 9.Lymphoedema Framework (2006) Best practice for the management of lymphoedema. International consensus, MEP Ltd, LondonGoogle Scholar
- 10.Oncology Nursing Society (2017) Lymphedema, https://www.ons.org/practice-resources/pep/lymphedema. Accessed 25 Nov 2017
- 13.Creswell JW (2007) Qualitative inquiry and research design: choosing among five traditions. Sage Publications, Thousand OaksGoogle Scholar
- 15.Jeffs E, Huit M (2015) Treatment and outcomes of head and neck oedema referrals to a hospital-based lymphoedema service. Br J Community Nurs Suppl:S6-S13. doi: https://doi.org/10.12968/bjcn.2015.20.Sup4.S6
- 19.Smile TD, Tendulkar R, Schwarz G, et al. (2016) A review of treatment for breast cancer-related lymphedema: paradigms for clinical practice. Am J Clin Oncol, Advance online publicationGoogle Scholar